Stockscreener 앱 받기
8.3695
2.63%
0.1895
Emergent Biosolutions Inc 주식(EBS)의 최신 뉴스
Emergent BioSolutions highlights its role in specialty vaccines as investors weigh the long-term out - AD HOC NEWS
Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today? - Stocktwits
Insider Sell: Paul Williams Sells 3,000 Shares of Emergent BioSo - GuruFocus
Emergent BioSolutions | 4: Statement of changes in beneficial ownership of securities-Officer Williams Paul Anthony - Moomoo
Emergent BioSolutions SVP Williams sells $25,200 in common stock - Investing.com
Form 4 Emergent Biosolutions Inc For: 2 July By Investing.com - Investing.com Canada
Emergent BioSolutions (EBS) SVP sells 3,000 shares under plan - Stock Titan
Emergent BioSolutions | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
[144] Emergent BioSolutions Inc. SEC Filing - Stock Titan
Emergent BioSolutions Secures Contract Modification Valued At Approximately USD 52.7 Million From The United States Department Of Health And Human Services To Supply ACAM2000 - marketscreener.com
Emergent BioSolutions Secures New ACAM2000 Biodefense Contract - TipRanks
Emergent BioSolutions (NYSE: EBS) lands $52.7M U.S. ACAM2000 contract - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Emergent BioSolutions (EBS) Secures $52.7M Contract for Smallpox Vaccine Supply - GuruFocus
Emergent BioSolutions wins $52.7m smallpox vaccine contract By Investing.com - Investing.com South Africa
Emergent BioSolutions wins $52.7m smallpox vaccine contract - Investing.com
U.S. government adds $52.7M ACAM2000 order for smallpox preparedness - Stock Titan
Emergent BioSolutions Inc. Actuals & Estimates (NYSE:EBS) - TradingView
Emergent BioSolutions | 8-K: Current report - Moomoo
Emergent BioSolutions Inc. Actuals & Estimates (BOATS:EBS) - TradingView
EBS Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Emergent BioSolutions Inc. – NYSE:EBS - TradingView
Enterprise value to revenue forward of Emergent BioSolutions Inc. – BOATS:EBS - TradingView
Price to sales forward of Emergent BioSolutions Inc. – NYSE:EBS - TradingView
Emergent Biosolutions studies intranasal naloxone for opioid overdose response - Traders Union
Emergent BioSolutions Inc (EBS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Emergent BioSolutions Inc (EBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Emergent BioSolutions StockSunday background on the business and risk profile - AD HOC NEWS
Why Emergent’s Narcan nasal spray is becoming a quiet everyday life saver - AD HOC NEWS
Emergent BioSolutions Inc (EBS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Emergent BioSolutions Inc (EBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Emergent BioSolutions Inc (EBS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Emergent BioSolutions Inc (EBS) Institutional Confidence - TradingKey
Emergent BioSolutions Inc (EBS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Emergent BioSolutions Inc (EBS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Emergent BioSolutions Inc (EBS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Emergent BioSolutions Stock (US29089Q1058): Earnings Picture And Balance Sheet Under The Microscope - AD HOC NEWS
[Form 4] Emergent BioSolutions Inc. Insider Trading Activity - Stock Titan
Emergent BioSolutions (EBS) SVP has 694 shares withheld for RSU taxes - Stock Titan
Emergent BioSolutions (EBS) EVP uses 2,018 shares to cover RSU taxes - Stock Titan
Emergent BioSolutions (EBS) SVP reports 1,741-share tax withholding on RSU vesting - Stock Titan
Emergent BioSolutions Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come (NYSE:EBS) - Seeking Alpha
Emergent BioSolutions (EBS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading - WSJ
SoRite Company Delivers Narcotics Decontamination to Rapid Risk Reduction's ONEbox Solutions - Yahoo Finance
U.S. – Johnson & Johnson in charge of Baltimore vaccine facility - Digital Journal
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose - The Manila Times
Emergent (EBS) Q1 2026 Earnings Transcript - AOL.com
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Emergent Biosolutions (EBS) and Compass Therapeutics (CMPX) - The Globe and Mail
H.C. Wainwright Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $12 - Moomoo
EBSEmergent Biosolutions Inc Latest SEC Filings - Finviz
Emergent BioSolutions (EBS) Consolidates Near Key Support After Flat SessionJurik MA - thelegaladvocate.com
Emergent BioSolutions (EBS) Secures $64.5M Contract Modification - GuruFocus
Emergent BioSolutions receives $64.5 million contract modification for BAT® to support U.S. biodefense strategy - marketscreener.com
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)(Equine)] to Support U.S. Biodefense Strategy - The Manila Times
Emergent Biosolutions Receives $64.5 Million Contract Modification For Bat® To Support U.S. Biodefense Strategy - TradingView
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin ... - Caledonian Record
U.S. health agency awards $64.5M botulism antitoxin deal to Emergent - Stock Titan
0.17%
1.69%
자본화:
|
볼륨(24시간):